Literature DB >> 22580943

Factors predictive of 30-day postoperative mortality in HIV/AIDS patients in the era of highly active antiretroviral therapy.

Sam M Wiseman1, Jamie I Forrest, Joe E Chan, Wendy Zhang, Benita Yip, Robert S Hogg, Viviane D Lima, Julio S G Montaner.   

Abstract

BACKGROUND: Factors that predict HIV (human immunodeficiency virus)/AIDS patient postoperative mortality have remained poorly defined.
OBJECTIVES: The primary objective of this study was to identify factors predictive of short-term, postoperative mortality in HIV/AIDS patients. The secondary objective of this study was to develop a scoring system that would predict short-term postoperative mortality in HIV/AIDS patients.
METHODS: We retrospectively reviewed all HIV/AIDS patients who underwent surgical procedures in British Columbia, Canada, between April 1995 and March 2002. The primary outcome evaluated was 30-day postoperative mortality. Demographic, clinical, and hospitalization-related data were obtained and utilized to predict outcomes using a logistic regression model.
RESULTS: A total of 2305 procedures were carried out on 1322 patients during the study period. Admissions were classified as urgent/emergent for 1311 procedures (57%) and the overall 30-day postoperative mortality was 9.5% (126 deaths). Urgent/emergent admission, older age, prior surgery, a CD4 cell count of ≤ 50 cells/mm, a hemoglobin level ≤ 120 g/L, and a white blood cell count >11 g/L within 90 days before the surgical procedure was predictive of an increased 30-day postoperative mortality in a multivariate model. Using these variables, we formulated the HIV Surgical Mortality Score (HSMS) to obtain the median-estimated probability of postoperative death.
CONCLUSIONS: For accurate preoperative mortality risk stratification for HIV/AIDS patients, we have found that several clinical and laboratory variables must be evaluated. If appropriately validated, our proposed HSMS could be utilized to estimate the probability of short-term postoperative death among HIV/AIDS patients.

Entities:  

Mesh:

Year:  2012        PMID: 22580943     DOI: 10.1097/SLA.0b013e318255896b

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  3 in total

1.  Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators.

Authors:  Joseph T King; Melissa F Perkal; Ronnie A Rosenthal; Adam J Gordon; Stephen Crystal; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; David Rimland; Michael S Simberkoff; Amy C Justice
Journal:  JAMA Surg       Date:  2015-04       Impact factor: 14.766

2.  Development and validation of a prognostic nomogram for HIV/AIDS patients who underwent antiretroviral therapy: Data from a China population-based cohort.

Authors:  Xiangqing Hou; Dayong Wang; Jingjing Zuo; Jushuang Li; Tao Wang; Chengnan Guo; Fang Peng; Dehua Su; Lina Zhao; Zhenmiao Ye; Hemei Zhang; Chao Zheng; Guangyun Mao
Journal:  EBioMedicine       Date:  2019-10-05       Impact factor: 8.143

3.  Development of a prognostic score using the complete blood cell count for survival prediction in unselected critically ill patients.

Authors:  Fang Chongliang; Li Yuzhong; Shi Qian; Liu Xiliang; Liu Hui
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.